Keywords: Paladin Labs, Isotechnika, Voclosporin, Bristol-Myers Squibb, Tempra, Pain releif, Transplantation, Autoimmune diseases

Paladin gets $1 million in amended deal with Isotechnika; acquires Tempra from for Canada

Article | 04 February 2011

Print This

Canadian specialty drugmaker Paladin Labs (TSX: PLB) says that it has agreed to amend its partnership with Isotechnika Pharma (TSX: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in